Galapagos Expands Chemistry Services Through Contracts with Indian Companies

Galapagos NV has announced that its service division BioFocus DPI has signed collaborations with Indus Biosciences, a subsidiary of CiVentiChem LLC in Hyderabad, and ProCitius, a division of Sanmar Speciality Chemicals Limited in Chennai, both providers of integrated chemistry services to life sciences companies. 

Both companies will carry out chemistry services for the BioFocus DPI Discovery Products division, with an option to provide support for client projects conducted by the BioFocus DPI Medicinal Chemistry division.

This outsourcing enables BioFocus DPI and its partners to benefit from the chemistry services available on the Indian sub-continent, while also enabling its clients to outsource work into Indus BioSciences and Sanmar under the management of BioFocus DPI scientists.

"These strategic outsourcing agreements with CiVentiChem and Sanmar complement our acquisition of DPI's drug discovery operations," said Onno van de Stolpe, CEO of Galapagos. 

"Our therapeutic programs, the alliance with GSK and the continuing growth of the BioFocus DPI customer base demand access to additional chemistry resources, and this is a timely move to ensure cost-effective capacity moving forward."

"We are very pleased that Galapagos and BioFocus DPI have chosen CiVentiChem and its subsidiary Indus Biosciences for our value-added services in discovery R&D chemistry and custom synthesis to complement their internal capabilities," said Bhaskar Venepalli, PhD, President and CEO of CiVentiChem.

"We are delighted to collaborate with BioFocus DPI," said Murli Ramachandran, Managing Director, Sanmar Speciality Chemicals Ltd.

"We believe that the target discovery and drug discovery services of BioFocus DPI would be well complemented by the chemistry research skills of ProCitius, enabling this partnership to deliver immense value to life sciences companies."